According to research report the Spatial Genomics and Transcriptomics Market is set to experience significant growth, with projections indicating an increase from USD 355 million in 2022 to USD 800 million by 2027, at a CAGR of 17.6%. Key factors driving this growth include the increasing adoption of these techniques for drug discovery and development, as well as rising R&D investments and public-private funding. Additionally, the introduction of advanced instruments for spatial genomics analysis is boosting market expansion.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170900551
Dominance of Spatial Transcriptomics Techniques
The market is segmented into spatial transcriptomics techniques and spatial genomics analysis techniques. In 2021, spatial transcriptomics techniques accounted for the largest share of the global market. This dominance is due to the high adoption of these techniques in drug discovery and development, the introduction of novel products, and significant R&D investments and public-private funding.
Rapid Growth in Consumables Segment
By product, the market is divided into consumables, instruments, and software. In 2021, the consumables segment held the largest share. The growth of this segment can be attributed to the expanding applications of spatial genomics and transcriptomics in drug discovery, development, and biomarker identification, alongside the increasing use of consumables in these processes.
Regional Insights: North America Leads the spatial transcriptomics market share
North America holds the largest share of the spatial genomics market, followed by Europe. The region's dominance is due to a strong focus on drug discovery and development, driven by the rising incidence of chronic and genetic diseases, and an aging population. These factors support the widespread adoption and use of spatial genomics and transcriptomics technologies in this region.
Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=170900551
The spatial genomics industry is consolidated in nature with prominent players in the spatial genomics & transcriptomics market include NanoString Technologies, Inc. (US), 10X Genomics (US), Illumina (US), Bio-Rad Laboratories (US), Bio-Techne Corporation (US), Standard BioTools Inc. (US), Genomic Vision SA (France), Akoya Biosciences, Inc. (US), Danaher Corporation (US), Natera, Inc. (US), PerkinElmer, Inc. (US), Seven Bridges Genomics (US), S2 Genomics, Inc. (US), Cantata Bio (US), Vizgen Corporation (US), BioSpyder Technologies Inc. (US), Optical Biosystems Inc. (US), Miltenyi Biotec (Germany), Ultivue Inc. (US), Lunaphore Technologies SA (Switzerland), Rebus Biosystems LLC (US), Resolve Biosciences (Germany), Singular Genomics, Inc. (US), and Veracyte (US).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com